This Is A Time To Invest In MBX Biosciences Inc (NASDAQ: MBX)

MBX Biosciences Inc (NASDAQ:MBX)’s traded shares stood at 0.57 million during the last session. At the close of trading, the stock’s price was $12.34, to imply an increase of 0.65% or $0.08 in intraday trading. The MBX share’s 52-week high remains $27.50, putting it -122.85% down since that peak but still an impressive 23.66% since price per share fell to its 52-week low of $9.42. The company has a valuation of $412.37M, with an average of 0.33 million shares in intraday trading volume over the past 10 days and average of 263.28K shares over the past 3 months.

MBX Biosciences Inc (NASDAQ:MBX) trade information

After registering a 0.65% upside in the last session, MBX Biosciences Inc (MBX) has traded red over the past five days. The 5-day price performance for the stock is 23.28%, and -15.48% over 30 days. With these gigs, the year-to-date price performance is -33.04%. Short interest in MBX Biosciences Inc (NASDAQ:MBX) saw shorts transact 1.67 million shares and set a 5.33 days time to cover.

The extremes give us $44 and $44 for target low and target high price respectively. As such, MBX has been trading -256.56% off suggested target high and -256.56% from its likely low.

MBX Dividends

MBX Biosciences Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Franklin Strategic Series-Franklin Biotechnology Discove and Driehaus Micro Cap Growth Fund as the top two Mutual Funds with the largest holdings of the MBX Biosciences Inc (MBX) shares. Going by data provided on Oct 31, 2024 , Franklin Strategic Series-Franklin Biotechnology Discove holds roughly 164.5 shares. This is just over 0.49% of the total shares, with a market valuation of $2.03 million. Data from the same date shows that the other fund manager holds a little less at 96.78, or 0.29% of the shares, all valued at about 1.19 million.